secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autonomix Medical, Inc. (AMIX)
CIK:        0001617867
Form:       8-K
Filed at:   2026-09-16T12:35:57+00:00
Accession:  0001437749-26-030505
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autonomix Medical appoints former Medtronic Chief Regulatory Counsel Sandra Kalter to board
--------------------------------------------------------------------------------

- Board expanded from five to six members; Kalter appointed independent director effective Sept 14, 2026.
- Kalter spent 20 years at Medtronic, including VP and Chief Regulatory Counsel; oversaw due diligence for 27+ acquisitions.
- Her Medtronic work covered Symplicity Spyral renal denervation, Evolut TAVR, Micra TPS, and PulseSelect PFA systems.
- She receives standard non-employee director compensation; no committee assignments or disclosed conflicts reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/0001437749-26-030505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1617867/000143774926030505/amix20260914_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-030505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer